Type 2 diabetes has a complex relationship with breast cancer risk and outcome; coexisting obesity may be a major factor, but insulin itself induces adipose aromatase activity and estrogen production and also directly stimulates breast cancer cell growth and invasion. The gene discussed is CYP19A1; the disease is obesity due to melanocortin 4 receptor deficiency.